The Food and Drug Administration has approved Amgen’s drug Aimovig for the prevention of migraines. This is the very first drug to prevent migraine headaches in adults. It works with interfering with calcitonin gene-related peptide (CGRP), which is involved in the processes that kick off a migraine, such as dilation of blood vessels in the … Continue reading “Amgen Migraine Preventive Drug gets FDA Approval”
